0001203311-17-000036.txt : 20170731 0001203311-17-000036.hdr.sgml : 20170731 20170731191558 ACCESSION NUMBER: 0001203311-17-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170727 FILED AS OF DATE: 20170731 DATE AS OF CHANGE: 20170731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRACHMAN JONATHAN G CENTRAL INDEX KEY: 0001588467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 17994278 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-07-27 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001588467 DRACHMAN JONATHAN G 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 CMO & EVP, R & D Common Stock 2017-07-27 4 M 0 10000 10.29 A 125204 D Common Stock 2017-07-27 4 S 0 10000 54.5361 D 115204 D Non-Qualified Stock Option (right to buy) 10.29 2017-07-27 4 M 0 10000 0.0 D 2017-08-28 Common Stock 10000 10000 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $54.10 to $54.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Shares vested at a rate of 25% on 8/28/2008 and monthly thereafter until all the shares were fully vested on 8/28/2011. /s/ Jean Liu 2017-07-28